What is Hinge Health, Inc. (HNGE)?
Hinge Health, Inc. trades as HNGE on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-03.
Is HNGE in a Closelooknet index?
Not currently — Hinge Health, Inc. is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-03.
What is Hinge Health, Inc.'s Closelooknet composite score?
56 out of 100, with momentum 98, quality 63 and valuation 21 sub-scores, as of 2026-11-03. Scores are Closelooknet's own research readings, not ratings or investment advice.
Where does HNGE trade against its moving averages?
Hinge Health, Inc. trades 17.0% above its 50-day and 71.3% above its 200-day moving average (7.5% above its 20-day). As of 2026-11-02 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How does Hinge Health, Inc. compare with its peers?
Against its peer group (Health Information Services · US), Hinge Health, Inc. (HNGE) sits 2.8% below its 52-week high, 17.0% above its 50-day average; HealthEquity Inc (HQY) is 3.7% below, Veeva Systems Inc Class A (VEEV) is 4.0% below, HealthStream Inc (HSTM) is 2.9% below, as of 2026-11-02. Put any of them next to HNGE in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
How does Hinge Health, Inc. trade when bond yields rise?
Over the past year Hinge Health, Inc. had a beta of 0.54 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 49% of US names. On the 10 sessions in which long bonds fell most it moved −1.58% on average, against −0.74% for the S&P 500. As of 2026-11-02; The "How it trades on rate days" block on this page carries the lines.
What does Hinge Health, Inc. do?
Hinge Health builds a digital platform for musculoskeletal care, covering acute injury, chronic pain and post-surgical rehabilitation. It uses AI-based motion tracking and a wearable nerve-stimulation device to guide exercise and monitor recovery remotely. The company sells mainly to self-insured employers who cover the cost as part of workforce health benefits. The diary has no peer group set for Hinge Health yet; the comparison the market draws is with Omada Health, another digital-health platform that reached the public market around the same period. (Company snapshot of 2026-09-17.)
Where does Hinge Health, Inc. sit in the AI build-out?
Hinge Health carries no seat in Closelooknet's index; it sits in the healthcare sleeve of our universe, under digital health and health information services. It applies AI to physical therapy delivery rather than to chip, data-centre or model infrastructure, so it sits outside the AI build-out stack the diary otherwise tracks. Hinge Health carries a Closelooknet score, but only one module has been scored so far, so the read is still being built. It holds no seat in our index and has not yet attracted a quote in the diary. (Company snapshot of 2026-09-17.)
Does Hinge Health, Inc. pay a dividend?
No cash distribution shows in Hinge Health, Inc.’s price series over the last three years. In fiscal 2025 the company bought back 65 m USD of its own shares, 38% of that year’s free cash flow. The share count rose 4.7% over the fiscal year. As of 2026-11-02; the "Dividends and capital return" block on this page carries the lines.
What has Wall Street done on Hinge Health, Inc. recently?
The most recent analyst action on Hinge Health, Inc. on the Closelooknet wire is a price target by Stifel on 2026-10-26 (target 130 from 115). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.
What does this page show?
A live price chart with SMA overlays and drawing tools for HNGE, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.